Our Vision
Harnessing Fluorescence to Advance Urine Drug Testing
At UPTru we are developing new ways to improve the clinical utility of urine drug testing by reducing the impact of specimen substitution and alteration on the validity of test results.
Our lead innovation is a patented point-of-care methodology based on fluorescein sodium, a safe and effective compound approved for a range of clinical indications.
Application of our technology identifies specimens that are altered through urine substitution (estimated to be approximately 7% of specimens).
Our Mission
UPTru aims to enhance clinical care and workplace safety by ensuring reliability and efficiency of point-of-care urine drug testing, while maintaining respect and building trust between patients and those delivering their primary care and between employers and their employees.
